title: Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity.
abstract: Tumor-associated myeloid cells have been implicated in regulating many of the "hallmarks of cancer" and thus fostering solid tumor development and metastasis. However, the same innate leukocytes also participate in anti-tumor immunity and restraint of malignant disease. While many factors regulate the propensity of myeloid cells to promote or repress cancerous growths, polarized adaptive immune responses by B and T lymphocytes have been identified as regulators of many aspects of myeloid cell biology by specifically regulating their functional capabilities. Here, we detail the diversity of heterogeneous B and T lymphocyte populations and their impacts on solid tumor development through their abilities to regulate myeloid cell function in solid tumors.
authors.affiliation: Department of Pathology, University of California, 513 Parnassus Ave., HSW-450C, San Francisco, CA 94143, USA.
authors.forename: David G
authors.initials: DG
authors.lastname: DeNardo
authors.forename: Pauline
authors.initials: P
authors.lastname: Andreu
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Coussens
mesh_terms: D000818:Animals; D006801:Humans; D008214:Lymphocytes / Q000276:immunology*; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D022423:Myeloid Cells / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology*
references.citation: Nat Immunol. 2009 Jul;10(7):689-95
references.pmid: 19536194
references.citation: Nat Rev Immunol. 2008 May;8(5):337-48
references.pmid: 18408735
references.citation: Cancer Cell. 2009 Aug 4;16(2):91-102
references.pmid: 19647220
references.citation: Immunity. 2007 Oct;27(4):635-46
references.pmid: 17919943
references.citation: J Hepatol. 2009 May;50(5):980-9
references.pmid: 19329213
references.citation: Clin Cancer Res. 2007 Apr 1;13(7):2075-81
references.pmid: 17404089
references.citation: J Exp Med. 2007 May 14;204(5):1037-47
references.pmid: 17438063
references.citation: J Exp Med. 2008 Jun 9;205(6):1261-8
references.pmid: 18490490
references.citation: Clin Cancer Res. 2006 Sep 15;12(18):5423-34
references.pmid: 17000676
references.citation: Cancer Cell. 2005 Sep;8(3):211-26
references.pmid: 16169466
references.citation: Cytokine Growth Factor Rev. 2010 Feb;21(1):3-10
references.pmid: 20005150
references.citation: Nature. 2007 Dec 6;450(7171):903-7
references.pmid: 18026089
references.citation: Immunol Lett. 1999 Jun 15;69(1):5-6
references.pmid: 10436874
references.citation: Nat Med. 1998 May;4(5):627-30
references.pmid: 9585241
references.citation: Int Immunol. 1998 Aug;10(8):1057-65
references.pmid: 9723691
references.citation: J Exp Med. 2003 Sep 1;198(5):747-55
references.pmid: 12953094
references.citation: Semin Cancer Biol. 2000 Oct;10(5):351-7
references.pmid: 11100883
references.citation: Blood. 2003 Apr 1;101(7):2620-7
references.pmid: 12411307
references.citation: Int Arch Allergy Immunol. 1997 May-Jul;113(1-3):153-6
references.pmid: 9130508
references.citation: J Clin Oncol. 2009 Apr 10;27(11):1746-52
references.pmid: 19255331
references.citation: Genes Dev. 1999 Jun 1;13(11):1382-97
references.pmid: 10364156
references.citation: Immunity. 2006 Jun;24(6):677-688
references.pmid: 16782025
references.citation: Clin Cancer Res. 2008 Jun 1;14(11):3254-61
references.pmid: 18519750
references.citation: Cell. 2006 Feb 24;124(4):823-35
references.pmid: 16497591
references.citation: Cancer Res. 2005 Mar 1;65(5):2018-25
references.pmid: 15753402
references.citation: Cancer Immunol Immunother. 2000 Jan;48(10):541-9
references.pmid: 10630306
references.citation: Cancer Metastasis Rev. 2008 Mar;27(1):11-8
references.pmid: 18066650
references.citation: PLoS One. 2009 Aug 10;4(8):e6562
references.pmid: 19668347
references.citation: Nat Immunol. 2008 Mar;9(3):239-44
references.pmid: 18285775
references.citation: Cancer. 2006 Dec 15;107(12):2866-72
references.pmid: 17099880
references.citation: Anticancer Res. 1992 Sep-Oct;12(5):1463-6
references.pmid: 1332579
references.citation: Nat Rev Immunol. 2008 Dec;8(12):958-69
references.pmid: 19029990
references.citation: Clin Immunol. 2004 Sep;112(3):258-67
references.pmid: 15308119
references.citation: Nat Rev Cancer. 2005 Apr;5(4):263-74
references.pmid: 15776005
references.citation: Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15505-10
references.pmid: 18832156
references.citation: Cancer Cell. 2010 Feb 17;17(2):121-34
references.pmid: 20138013
references.citation: Cancer Res. 2006 Aug 1;66(15):7741-7
references.pmid: 16885377
references.citation: Cell. 2006 Jan 27;124(2):263-6
references.pmid: 16439202
references.citation: Trends Immunol. 2004 Dec;25(12):677-86
references.pmid: 15530839
references.citation: Immunity. 2005 Mar;22(3):371-83
references.pmid: 15780993
references.citation: Br J Cancer. 2005 Apr 11;92(7):1182-7
references.pmid: 15785750
references.citation: Carcinogenesis. 2009 Jul;30(7):1073-81
references.pmid: 19468060
references.citation: Immunity. 2004 Aug;21(2):137-48
references.pmid: 15308095
references.citation: Cancer Sci. 2006 Jul;97(7):568-74
references.pmid: 16827795
references.citation: J Immunol. 2007 Feb 1;178(3):1357-62
references.pmid: 17237382
references.citation: Cancer Res. 2006 Jan 15;66(2):605-12
references.pmid: 16423985
references.citation: Nat Rev Immunol. 2009 Feb;9(2):91-105
references.pmid: 19151746
references.citation: Nature. 2008 Jul 24;454(7203):436-44
references.pmid: 18650914
references.citation: J Immunol. 2005 Nov 1;175(9):6177-89
references.pmid: 16237115
references.citation: Cancer Cell. 2004 Oct;6(4):409-21
references.pmid: 15488763
references.citation: J Immunol. 2006 Jan 15;176(2):705-10
references.pmid: 16393950
references.citation: J Invest Dermatol. 2004 Mar;122(3):699-706
references.pmid: 15086556
references.citation: J Immunol. 2006 Apr 15;176(8):5023-32
references.pmid: 16585599
references.citation: Cancer Cell. 2009 Sep 8;16(3):183-94
references.pmid: 19732719
references.citation: Cancer Cell. 2005 Mar;7(3):211-7
references.pmid: 15766659
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):855-60
references.pmid: 16418262
references.citation: Blood. 2006 Nov 1;108(9):2957-64
references.pmid: 16825494
references.citation: Nat Rev Cancer. 2006 Jan;6(1):24-37
references.pmid: 16397525
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12493-8
references.pmid: 16891410
references.citation: Curr Opin Immunol. 2007 Apr;19(2):209-16
references.pmid: 17276050
references.citation: Cell. 2000 Jul 21;102(2):199-209
references.pmid: 10943840
references.citation: Immunity. 2009 May;30(5):646-55
references.pmid: 19464987
references.citation: Cancer Sci. 2003 Nov;94(11):1003-9
references.pmid: 14611679
references.citation: Adv Exp Med Biol. 2007;590:195-208
references.pmid: 17191387
references.citation: Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54
references.pmid: 17671115
references.citation: Curr Opin Immunol. 2005 Apr;17(2):180-6
references.pmid: 15766679
references.citation: Blood. 2005 Apr 1;105(7):2757-63
references.pmid: 15572584
references.citation: Biochim Biophys Acta. 2006 Aug;1766(1):159-66
references.pmid: 16857321
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Eur J Immunol. 2007 Jan;37(1):14-6
references.pmid: 17183610
references.citation: Curr Opin Genet Dev. 2008 Feb;18(1):11-8
references.pmid: 18308558
references.citation: Neoplasia. 1999 Nov;1(5):453-60
references.pmid: 10933061
references.citation: Nature. 2010 Mar 11;464(7286):302-5
references.pmid: 20220849
references.citation: Immunity. 2009 Nov 20;31(5):787-98
references.pmid: 19879162
references.citation: Curr Opin Rheumatol. 2007 May;19(3):289-95
references.pmid: 17414958
references.citation: J Immunol. 1989 Feb 1;142(3):760-5
references.pmid: 2464024
references.citation: Nature. 2008 Jun 19;453(7198):1051-7
references.pmid: 18563156
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51
references.pmid: 18042719
references.citation: Immunity. 2008 Apr;28(4):454-67
references.pmid: 18400188
references.citation: Am J Pathol. 1996 Dec;149(6):1899-917
references.pmid: 8952526
references.citation: Ann N Y Acad Sci. 2010 Jan;1183:38-57
references.pmid: 20146707
references.citation: Nat Rev Immunol. 2007 Apr;7(4):279-91
references.pmid: 17380157
references.citation: Eur Respir J Suppl. 1995 Sep;20:668s-675s
references.pmid: 8590567
references.citation: Nat Rev Cancer. 2004 Jan;4(1):71-8
references.pmid: 14708027
references.citation: Cancer Res. 2004 Oct 1;64(19):7022-9
references.pmid: 15466195
references.citation: J Clin Invest. 2004 Nov;114(9):1209-17
references.pmid: 15520849
references.citation: Annu Rev Immunol. 1993;11:331-60
references.pmid: 8476565
references.citation: Semin Cancer Biol. 2006 Feb;16(1):53-65
references.pmid: 16168663
references.citation: Nat Rev Immunol. 2004 Aug;4(8):583-94
references.pmid: 15286725
references.citation: Int J Cancer. 2005 Nov 20;117(4):574-86
references.pmid: 15912532
references.citation: Blood. 2009 May 7;113(19):4595-603
references.pmid: 19074733
references.citation: Int J Biochem Cell Biol. 2005 Mar;37(3):628-36
references.pmid: 15618019
references.citation: Nat Med. 2009 Sep;15(9):1016-22
references.pmid: 19701202
references.citation: J Exp Med. 2003 Apr 21;197(8):1017-28
references.pmid: 12695493
references.citation: Immunol Invest. 2006;35(3-4):327-57
references.pmid: 16916757